Journal of Gastric Cancer

The Korean Gastric Cancer Association (대한위암학회)
권호 표지
DOI QR코드

DOI QR Code

Bone Metastasis from Gastric Cancer: The Incidence, Clinicopathological Features, and Influence on Survival

  • Turkoz, Fatma Paksoy (Ataturk Chest Disease and Chest Surgery Training and Research Hospital, Department of Medical Oncology) ;
  • Solak, Mustafa (Hacettepe University Cancer Institute, Department of Medical Oncology) ;
  • Kilickap, Saadettin (Hacettepe University Cancer Institute, Department of Medical Oncology) ;
  • Ulas, Arife (Ankara Ataturk Training and Research Hospital, Department of Medical Oncology) ;
  • Esbah, Onur (Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Department of Medical Oncology) ;
  • Oksuzoglu, Berna (Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Department of Medical Oncology) ;
  • Yalcin, Suayib (Hacettepe University Cancer Institute, Department of Medical Oncology)
  • Received : 2014.06.16
  • Accepted : 2014.08.26
  • Published : 2014.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: To evaluate the incidence, clinicopathological characteristics, treatment outcomes, prognostic factors, and survival of gastric cancer patients with bone metastases. Materials and Methods: Of 4,617 gastric cancer patients who were treated between 2001 and 2013, 176 patients with bone metastases were analyzed. Results: The incidence of bone metastasis was 3.8%. The most common histopathological subtype was adenocarcinoma (79%) with poor differentiation (60.8%). The median interval from the diagnosis to bone metastasis was 11 months. The median survival time after bone metastasis was 5.4 months. Factors that were associated with longer median survival times included the following: isolated bone metastasis (P=0.004), well-differentiated tumors (P=0.002), palliative chemotherapy (P=0.003), zoledronic acid treatment (P<0.001), no smoking history (P=0.007), and no metastatic gastric cancer at the time of diagnosis (P=0.01). On the other hand, high levels of lactate dehydrogenase (LDH) (hazard ratio [HR]: 1.86; P=0.015), carcinoembryonic antigen (CEA) (HR: 2.04; P=0.002), and carbohydrate antigen (CA) 19-9 (HR: 2.94; P<0.001) were associated with shorter survival times. In multivariate analysis, receiving zoledronic acid (P<0.001) and performance status (P=0.013) were independent prognostic factors. Conclusions: Smoking history, poor performance status, poorly differentiated adenocarcinoma, and high levels of LDH, CEA, and CA 19-9 were shown to be poor prognostic factors, while receiving chemotherapy and zoledronic acid were associated with prolonged survival in gastric cancer patients with bone metastases.

Keywords

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90. https://doi.org/10.3322/caac.20107
  2. International Agency for Research on Cancer. Globocan 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012 [Internet]. Lyon: International Agency for Research on Cancer; [cited 2014 Jun 15]. Available from: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx?country=792.
  3. Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis. Cancer 2000;88:921-932. https://doi.org/10.1002/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.0.CO;2-S
  4. Wanebo HJ, Kennedy BJ, Chmiel J, Steele G Jr, Winchester D, Osteen R. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 1993;218:583-592. https://doi.org/10.1097/00000658-199321850-00002
  5. Mori W, Adachi Y, Okabe H, Ohta K. An analysis of 755 autopsied cases of malignant tumors. A statistical study of their metastasis. Gan No Rinsho 1963;9:351-374.
  6. Nishidoi H, Koga S. Clinicopathological study of gastric cancer with bone metastasis. Gan To Kagaku Ryoho 1987;14:1717-1722.
  7. Choi CW, Lee DS, Chung JK, Lee MC, Kim NK, Choi KW, et al. Evaluation of bone metastases by Tc-99m MDP imaging in patients with stomach cancer. Clin Nucl Med 1995;20:310-314. https://doi.org/10.1097/00003072-199504000-00005
  8. Seto M, Tonami N, Koizumi K, Sui O, Hisada K. Bone metastasis in gastric cancer--clinical evaluation of bone scintigrams. Kaku Igaku 1983;20:795-801.
  9. Park HS, Rha SY, Kim HS, Hyung WJ, Park JS, Chung HC, et al. A prognostic model to predict clinical outcome in gastric cancer patients with bone metastasis. Oncology 2011;80:142-150. https://doi.org/10.1159/000328507
  10. Ahn JB, Ha TK, Kwon SJ. Bone metastasis in gastric cancer patients. J Gastric Cancer 2011;11:38-45. https://doi.org/10.5230/jgc.2011.11.1.38
  11. Park JM, Song KY, O JH, Kim WC, Choi MG, Park CH. Bone recurrence after curative resection of gastric cancer. Gastric Cancer 2013;16:362-369. https://doi.org/10.1007/s10120-012-0193-y
  12. Yoshikawa K, Kitaoka H. Bone metastasis of gastric cancer. Jpn J Surg 1983;13:173-176. https://doi.org/10.1007/BF02469472
  13. Silvestris N, Pantano F, Ibrahim T, Gamucci T, De Vita F, Di Palma T, et al. Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey. PLoS One 2013;8:e74402. https://doi.org/10.1371/journal.pone.0074402
  14. Nakanishi H, Araki N, Kuratsu S, Narahara H, Ishikawa O, Yoshikawa H. Skeletal metastasis in patients with gastric cancer. Clin Orthop Relat Res 2004;(423):208-212.
  15. Sudo H, Takagi Y, Katayanagi S, Hoshino S, Suda T, Hibi Y, et al. Bone metastasis of gastric cancer. Gan To Kagaku Ryoho 2006;33:1058-1060.
  16. Kobayashi M, Okabayashi T, Sano T, Araki K. Metastatic bone cancer as a recurrence of early gastric cancer -- characteristics and possible mechanisms. World J Gastroenterol 2005;11:5587-5591.
  17. Batson OV. The function of the vertebral veins and their role in the spread of metastases. 1940. Clin Orthop Relat Res 1995;(312):4-9.
  18. Lehnert T, Erlandson RA, Decosse JJ. Lymph and blood capillaries of the human gastric mucosa. A morphologic basis for metastasis in early gastric carcinoma. Gastroenterology 1985;89:939-950. https://doi.org/10.1016/0016-5085(85)90192-1
  19. Kilickap S, Tapan U, Yalcin S. Metastasis to bone from gastric cancer: a single centre experience. Cumhuriyet Med J 2010;32:192-198.
  20. Aapro M, Abrahamsson PA, Body JJ, Coleman RE, Colomer R, Costa L, et al. Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel. Ann Oncol 2008;19:420-432.
  21. Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol 2006;24:2903-2909. https://doi.org/10.1200/JCO.2005.05.0245

Cited by

  1. Effect of expressions of tumor necrosis factor α and interleukin 1B on peritoneal metastasis of gastric cancer vol.36, pp.11, 2014, https://doi.org/10.1007/s13277-015-3621-x
  2. Clinicopathologic and Prognostic Value of Serum Carbohydrate Antigen 19-9 in Gastric Cancer: A Meta-Analysis vol.2015, pp.None, 2014, https://doi.org/10.1155/2015/549843
  3. A Rare Initial Presentation of Gastric Cancer with Multiple Osteolytic Lesions vol.2015, pp.None, 2014, https://doi.org/10.1155/2015/689431
  4. Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case report vol.9, pp.3, 2014, https://doi.org/10.3892/ol.2014.2822
  5. Clinicopathological features of gastric adenocarcinoma patients with metachronous distant metastasis vol.36, pp.8, 2014, https://doi.org/10.1007/s13277-015-3325-2
  6. Bone metastasis as the first sign of gastric cancer vol.28, pp.None, 2014, https://doi.org/10.11604/pamj.2017.28.95.13787
  7. Bicytopenia and leukoerythroblastosis: a rare initial presentation of signet ring cell gastric adenocarcinoma vol.7, pp.2, 2014, https://doi.org/10.4322/acr.2017.014
  8. Clinical outcomes and prognostic factors for gastric cancer patients with bone metastasis vol.15, pp.None, 2017, https://doi.org/10.1186/s12957-016-1091-2
  9. Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: A SEER ‐based study vol.7, pp.8, 2014, https://doi.org/10.1002/cam4.1661
  10. The function of Notch1 intracellular domain in the differentiation of gastric cancer vol.15, pp.5, 2014, https://doi.org/10.3892/ol.2018.8118
  11. Metastatic Gastric cancer: Real world scenario from a developing country vol.7, pp.3, 2018, https://doi.org/10.4103/sajc.sajc_2_18
  12. Long-term survival after gastrectomy and metastasectomy for gastric cancer with synchronous bone metastasis vol.24, pp.1, 2014, https://doi.org/10.3748/wjg.v24.i1.150
  13. 68Ga-labelled PSMA (prostate specific membrane antigen) expression in signet-ring cell gastric carcinoma vol.45, pp.7, 2014, https://doi.org/10.1007/s00259-018-3993-4
  14. Systematic review: Incidence, risk factors, survival and treatment of bone metastases from colorectal cancer vol.13, pp.None, 2014, https://doi.org/10.1016/j.jbo.2018.09.009
  15. Gastric cancer initially presenting as bone metastasis: Two case reports and a literature review vol.16, pp.5, 2014, https://doi.org/10.3892/ol.2018.9393
  16. Bone metastases with multiple fluid-fluid levels from gastric cancer: a case report and review of literature vol.48, pp.5, 2019, https://doi.org/10.1007/s00256-018-3075-5
  17. Clinical analysis of bone metastasis of gastric cancer: incidence, clinicopathological features and survival vol.15, pp.19, 2019, https://doi.org/10.2217/fon-2019-0039
  18. Stoichiogenomics reveal oxygen usage bias, key proteins and pathways associated with stomach cancer vol.9, pp.1, 2019, https://doi.org/10.1038/s41598-019-47533-6
  19. A Population-Based Analysis of Distant Metastasis in Stage IV Gastric Cancer vol.26, pp.None, 2014, https://doi.org/10.12659/msm.923867
  20. Prognostic Value of the Site of Distant Metastasis and Surgical Interventions in Metastatic Gastric Cancer: A Population-Based Study vol.19, pp.None, 2014, https://doi.org/10.1177/1533033820964131
  21. Risk factors and prognosis of bone metastases in newly diagnosed gastric cancer vol.16, pp.12, 2014, https://doi.org/10.2217/fon-2019-0728
  22. Prognostic factors and skeletal-related events in patients with bone metastasis from gastric cancer vol.13, pp.4, 2014, https://doi.org/10.3892/mco.2020.2101
  23. A Diagnostic Nomogram Based on 18F-FDG PET/CT for Bone Metastasis of Gastric Cancer vol.9, pp.None, 2014, https://doi.org/10.3389/fcell.2021.783466
  24. Varied functions of immune checkpoints during cancer metastasis vol.70, pp.3, 2014, https://doi.org/10.1007/s00262-020-02717-2
  25. Bone Metastases from Gastric Cancer: What We Know and How to Deal with Them vol.10, pp.8, 2014, https://doi.org/10.3390/jcm10081777
  26. Advanced esophagogastric junction cancer with brain, bone and gastric intramural metastases responding to combined modality therapy vol.16, pp.3, 2021, https://doi.org/10.2185/jrm.2020-055
  27. Clinicopathologic characteristics, metastasis-free survival, and skeletal-related events in 628 patients with skeletal metastases in a tertiary orthopedic and trauma center vol.19, pp.1, 2014, https://doi.org/10.1186/s12957-021-02169-7
  28. A case of disseminated carcinomatosis of the bone marrow from gastric cancer developing rapidly after a gastrectomy vol.7, pp.1, 2021, https://doi.org/10.1186/s40792-021-01135-5